BERLIN--(BUSINESS WIRE)--EBS Technologies (“EBS”) announced today that it has opened a second clinic in Germany to treat patients who have impaired vision using its patented noninvasive electrical brain stimulation system— NEXT WAVE™—to expand the patients’ visual field.
A clinical study (“Brain functional connectivity network breakdown and restoration in blindness”) published recently in the journal Neurology® validated non-invasive brain stimulation for restoring partial vision to an impaired eye. The Company’s NEXT WAVE™ system is a non-invasive brain stimulation device that is designed to expand the visual field of patients with impaired vision caused by glaucoma or stroke or other neurological diseases. NEXT WAVE™ is approved for sale in Europe.
Help employers find you! Check out all the jobs and post your resume.
